Trial

TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment

Study Director
Start Date
12 / 2008
Trial Phase
Phase II
Trial Status
published
Current Enrollment
531
Target Enrollment
800
Overview

Randomized, Phase II clinical trial assessing the antimicrobial activity and safety of substitution of rifapentine for rifampin in standard intensive phase TB treatment regimen.

Developer Associations
CDC TBTC
Sanofi
Trial Site Associations
National TB Program/UC San Francisco (TBTC Site 37)